Derivatives quinazolines are of special importance because of their versatile biological activities\[[@CIT1][@CIT2]\], especially antihistaminic\[[@CIT3]\], antiinflammatory\[[@CIT4]\], antihypertensive\[[@CIT5]\], antiHIV\[[@CIT6]\], antifungal\[[@CIT6][@CIT7]\], antimicrobial\[[@CIT8][@CIT9]\], anticonvulsant\[[@CIT10]\], antithrombotic\[[@CIT11]\], antitubercular\[[@CIT12][@CIT13]\], antitumor\[[@CIT14]\], analgesic\[[@CIT15]\], antibacterial\[[@CIT6][@CIT15]\] and insecticidal\[[@CIT16]\]. In this paper, a new route for the synthesis of pyrazolo quinazolinones is reported.

The strategy employed for the synthesis of desired compounds involved the sequential treatment of anthranilic acid with thiocarbamate salts of substituted aniline and carbon disulphide to give substituted 2-thio-3-aryl quinazol-4(3H)ones (1). The appearance of broad band at 3330-3110 cm^-1^ in IR spectrum and a singlet displayed at δ, 10-13 ppm in the PMR spectrum due to -SH supports their formation. Compound (1) were refluxed with excess hydrazine hydrate to form 2-hydrazino derivative (2), the formation witch has been explained by the appearance of IR band at 3390-3100 cm^-1^ due to -NHNH~2~ and disappearance of signal observed at δ, 10-13 ppm due to -SH and the appearance of two additional singlet between δ, 9-11 and δ, 2-7 ppm due to -NH and -NH~2~ protons, respectively in their PMR spectra. The condensation of (2) with variously substituted aryl aldehydes gave the corresponding hydrazones (3). The appearance -NH and =CH protons at δ, 5.1 and δ, 8.2 in PMR spectrum and also disappearance of -NH~2~ band 3390-3200 cm^-1^ in IR spectrum indicated their formation. Further, the cyclization of compound (3) in acetic anhydride gave tricyclic triazolo quinazolones (4). The formation of these compounds have been established by the disappearance of the PMR singlet due to -NH and =CH displayed at δ, 5.1 and δ, 8.2, respectively in the PMR spectrum of (3).([Scheme 1](#F0001){ref-type="fig"})

![Synthetic route for synthesis of Quinazolin-4(3H)One derivatives](IJPhS-72-500-g001){#F0001}

All chemicals used were of AR grade and are used without further purification. Melting points were determined by open capillary method and are uncorrected. ^1^H NMR spectra in DMSO-d~6~ were scanned on a Bruker A-300 F-NMR spectrometer. IR spectra were recorded on a Perkin-Elmer 783 (FTIR) spectrophotometer. Purity of the products in addition to the elemental analysis was checked by TLC.

The starting compound (1) was prepared by reported method\[[@CIT17]\]. 2-Hydrazino 3-p-methoxy phenyl quinazolin-4(3H)one (2a) was synthesized as follows; The compound (la) (5.0 g, 0.018 mole) was refluxed with excess of hydrazine hydrate (15 ml) with constant stirring at 100°C for about 1 ½ h, cooled and the solid obtained was filtered and recrystallized from ethanol to furnish (2a), IR(KBr); 3386-3328 (-HNNH ~2~), 1664 (cyclic amido C=O) cm^-1^; ^1^H NMR (DMSO-d~6~): δ, 3.81(3H,s,Ar-OCH~3~), 6.25(2H,s,-NH~2~), 6.9-7.8(8H,m, Ar-H), 10.9(1H,s, br, -NH).

2-(p-Methoxybenzylidene)hydrazine-3-(p-methoxyphenyl)quinazolin-4-(3H)one (3a~-1~) was synthesized using following procedure; the mixture of compound (2a) (0.2 g, 0.0007 mole) and p-methoxy benzaldehyde (0.1 g, 0.0007 mole) in ethanol (10 ml) to which two drops of acetic acid were added and the reaction mixture heated on oil bath for 5 h. The separated solid was filtered under vacuum and further recrystallized from DMF, IR(KBr); 3100-3350(-NH), 1665 cm^-1^ (cyclic amido \>C=O), 1600 cm^-1^(-C=N); ^1^H NMR (DMSO-d~6~): 3.82 (3H, s, Ar-OCH~3~), 3.84 (3H, s, another Ar-OCH~3~), 6.00 (1H, s, br, -NH), 8.21 (1H, s, =CH), 6.8-8.1 (12H, m, Ar-H), 8.20 (=CH) ppm.

3,5'-(p-Dimethoxyphenyl) pyrazolo-\[3',4'-a\] quinazolin-4(3H)one (4~a-1~) was synthesized as follows; To a solution of compound (3~a-1~) (0.1 g, 0.00025 mole) in acetic anhydride (10 ml) was refluxed for about 2 h then poured in ice-cold water and separated solid was filtered, recrystallized from DMF to get desired tricyclic pyrazolo quinazolinones, IR (KBr): 1665 cm^-1^ (cyclic amido \> C=O) and 1620 cm^-1^ (C=N); ^1^H NMR: (DMSO-d~6~): 3.79 (3H, s, Ar-OCH~3~) 3.95(3H, s, another Ar-OCH~3~), 6.8-8.2(12H, m, Ar-H) ppm. ([Table 1](#T0001){ref-type="table"})

###### 

CHARACTERIZATION DATA OF COMPOUNDS 2, 3 AND 4

  S. No.   R Groups                  M.P.(o)   Yield (%)   Mol. Formula           \% C    \% H    \% N                  
  -------- ------------------------- --------- ----------- ---------------------- ------- ------- ------ ------ ------- -------
  2a       p-OCH~3~                  205       76          C~15~H~14~O~2~N~4~     63.82   63.76   5.00   5.10   19.85   19.90
  2b       p-CH~3~                   215       86          C~15~H~14~ON~4~        67.65   67.59   5.30   5.38   21.04   21.10
  2c       p-Cl                      218       82          C~14~H~11~ON~4~Cl      58.65   58.58   3.87   4.95   19.54   19.47
  2d       p-Br                      196       83          C~14~H~11~ON~4~Br      50.78   50.62   3.35   3.40   16.92   16.86
           R'groups                                                                                                     
  4~a-1~   p-OCH~3~C~6~H~4~          230       83          C~23~H~18~O~3~N~4~     69.34   69.45   4.55   4.41   14.06   13.86
  4~a-2~   o-NO~2~C~6~H~4~           193       78          C~22~H~15~O~4~N~5~     63.92   63.85   3.66   3.70   16.94   16.82
  4~a-3~   3,4,5(OCH~3~)3-C~6~H~2~   211       68          C~25~H~22~O~5~N~4~     65.49   67.00   4.84   4.89   12.22   12.18
  4~a-4~   o-OHC~6~H~4~              216       77          C~22~H~16~O~3~N~4~     68.74   68.80   4.20   4.16   14.58   14.49
  4~a-5~   p-OHC~6~H~4~              239       71          C~22~H~16~O~3~N~4~     68.74   68.65   4.20   4.18   14.58   14.50
  4~a-6~   o-ClC~6~H~4~              241       70          C~22~H~15~O~2~N~4~Cl   65.60   65.60   3.75   3.68   13.91   14.00
  4~a-7~   p-ClC~6~H~4~              235       72          C~22~H~15~ON~4~Cl      65.60   65.58   3.75   3.81   13.91   13.86
  4~a-8~   p-OH,m-OCH~3~-C~6~H~3~    243       78          C~23~H~18~O~4~N~4~     66.66   66.70   4.38   4.40   13.52   13.60
  4~b-1~   p-OCH~3~C~6~H~4~          198       86          C~23~H~18~O~2~N~4~     72.24   72.30   4.74   4.81   14.65   14.72
  4~b-2~   o-NO~2~C~6~H~4~           175       81          C~22~H~15~O~3~N~5~     66.49   66.40   3.80   3.75   17.62   17.70
  4~b-3~   3,4,5(OCH~3~)3-C~6~H~2~   203       78          C~25~H~22~O~4~N~4~     67.86   67.70   5.01   5.11   12.66   12.73
  4~b-4~   o-OHC~6~H~4~              218       68          C~22~H~16~O~2~N~4~     71.73   71.62   4.38   4.29   15.21   15.30
  4~b-5~   p-OHC~6~H~4~              221       62          C~22~H~16~O~2~N~4~     71.73   71.66   4.38   4.30   15.21   15.16
  4~b-6~   o-ClC~6~H~4~              216       72          C~22~H~15~ON~4~Cl      68.31   68.40   3.91   3.83   14.48   14.53
  4~b-7~   p-ClC~6~H~4~              235       72          C~22~H~15~ON~4~Cl      68.31   68.39   3.91   4.00   14.48   14.51
  4~b-8~   p-OH,m-OCH~3~-C~6~H~3~    235       81          C~23~H~18~O~3~N~4~     69.34   69.28   4.55   4.49   14.06   14.10
  4~c-1~   p-OCH~3~C~6~H~4~          246       86          C~22~H~15~O~2~N~4~Cl   65.60   64.30   3.75   3.81   13.91   13.84
  4~c-2~   o-NO~2~C~6~H~4~           198       82          C~21~H~12~O~3~N~5~Cl   60.37   60.45   2.89   2.81   16.76   16.68
  4~c-3~   3,4,5(OCH~3~)3-C~6~H~2~   261       79          C~24~H~24~O~4~N~4~Cl   62.27   62.32   4.14   4.21   12.10   12.05
  4~c-4~   o-OHC~6~H~4~              232       71          C~21~H~13~O~2~N~4~Cl   64.87   64.91   3.37   3.42   14.41   14.35
  4~c-5~   p-OHC~6~H~4~              222       69          C~21~H~13~O~2~N~4~Cl   64.87   65.00   3.37   3.40   14.41   14.50
  4~c-6~   o-ClC~6~H~4~              248       65          C~21~H~12~ON~4~Cl2     61.93   61.85   2.97   3.05   13.76   13.81
  4~c-7~   p-ClC~6~H~4~              242       80          C~21~H~12~ON~4~Cl2     61.93   61.86   2.97   3.10   13.76   13.82
  4~c-8~   p-OH,m-OCH~3~-C~6~H~3~    243       65          C~22~H~15~O~3~N~4~Cl   63.09   63.13   3.61   3.53   13.38   13.31
  4~d-1~   p-OCH~3~C~6~H~4~          246       86          C~21~H~15~O~2~N~4~Br   59.08   59.10   3.38   3.42   12.53   12.60
  4~d-2~   o-NO~2~C~6~H~4~           198       82          C~21~H~12~O~3~N~5~Br   54.56   54.50   2.62   2.56   15.15   15.10
  4~d-3~   3,4,5(OCH~3~)-C~6~H~2~    261       79          C~24~H~19~O~4~N~4~Br   56.82   56.89   3.77   3.68   11.04   11.12
  4~d-4~   o-OHC~6~H~4~              232       71          C~21~H~13~O~2~N~4~Br   58.22   58.16   3.02   3.11   12.93   12.84
  4~d-5~   p-OHC~6~H~4~              222       69          C~21~H~13~O~2~N~4~Br   58.22   58.31   3.02   3.12   12.93   12.86
  4~d-6~   o-ClC~6~H~4~              248       65          C~21~H~12~ON~4~ClBr    55.84   55.91   2.68   2.61   12.40   12.32
  4~d-7~   p-ClC~6~H~4~              218       73          C~21~H~12~ON~4~ClBr    55.84   55.80   2.68   2.73   12.40   12.46
  4~d-8~   p-OH,m-OCH~3~C~6~H~3~     226       78          C~23~H~18~O~4~N~4~Br   57.04   57.12   3.26   3.20   12.09   12.11

The antimicrobial screening of synthesized compounds was carried out by paper disc diffusion method\[[@CIT18]\] at 100 ppm against Gram +ve bacteria *B. substilis*, *S. aureus* and Gram --ve bacteria like *E. coli, P. vulgaris*. The antifungal activity of the compounds was assayed using fungal species *Aspergillus niger* and *Phytophora*. Standard antibacterial streptomycin and antifungal griseofulvin were also screened under similar condition for comparison. ([Table 2](#T0002){ref-type="table"})

###### 

ANTIMICROBIAL SCREENING DATA OF THE DERIVATIVES OF 4

  Comp     Bacteria   Fungi                  
  -------- ---------- ------- ---- ---- ---- ----
  4~a-1~   17         16      12   17   17   15
  4~a-2~   5          7       15   14   5    11
  4~a-3~   20         14      19   14   16   12
  4~a-4~   7          10      7    4    8    1
  4~a-5~   14         5       9    11   13   8
  4~a-6~   16         20      17   15   17   20
  4~a-7~   18         18      17   12   19   18
  4~a-8~   12         15      11   12   12   14
  4~b-1~   20         19      11   16   19   12
  4~b-2~   4          8       9    7    4    8
  4~b-3~   25         20      16   17   20   16
  4~b-4~   9          4       14   4    9    7
  4~b-5~   5          9       12   8    7    9
  4~b-6~   17         11      16   11   19   19
  4~b-7~   16         20      16   13   18   11
  4~b-8~   11         12      14   11   12   12
  4~c-1~   16         20      13   16   20   15
  4~c-2~   9          4       8    4    8    10
  4~c-3~   20         18      17   20   18   20
  4~c-4~   8          6       12   6    8    5
  4~c-5~   5          5       11   7    23   16
  4~c-6~   22         19      18   17   23   16
  4~c-7~   19         22      17   16   24   17
  4~c-8~   11         11      7    12   9    12
  4~d-1~   20         20      11   19   18   11
  4~d-2~   14         14      6    8    12   7
  4~d-3~   22         24      18   25   20   18
  4~d-4~   7          8       11   5    7    7
  4~d-5~   12         12      14   9    13   10
  4~d-6~   25         23      20   16   24   20
  4~d-7~   20         21      25   20   22   24
  4~d-8~   15         12      14   11   15   11

Diameter of zone of inhibition in milimeters

The result indicated that some compounds exhibit good antimicrobial activity against the above mentioned bacterial and fungal species, while some compounds have moderate antimicrobial activity against both Gram +ve and Gram --ve bacterial and fungal species. It was absovered that introduction of ^-^OCH~3~ and ^-^Cl groups to the heterocyclic frame work enhanced antibacterial and antifungal activities.

**Deshmukh, *et al*.: Antimicrobial Screening of Quinazolin-4(3H)ones**
